2wp3 Citations

Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex.

Proc Natl Acad Sci U S A 107 2908-13 (2010)
Related entries: 2wwk, 2wwm

Cited: 42 times
EuropePMC logo PMID: 20133654

Abstract

In the sarcomeric M-band, the giant ruler proteins titin and obscurin, its small homologue obscurin-like-1 (obsl1), and the myosin cross-linking protein myomesin form a ternary complex that is crucial for the function of the M-band as a mechanical link. Mutations in the last titin immunoglobulin (Ig) domain M10, which interacts with the N-terminal Ig-domains of obscurin and obsl1, lead to hereditary muscle diseases. The M10 domain is unusual not only in that it is a frequent target of disease-linked mutations, but also in that it is the only currently known muscle Ig-domain that interacts with two ligands--obscurin and obsl1--in different sarcomeric subregions. Using x-ray crystallography, we show the structural basis for titin M10 interaction with obsl1 in a novel antiparallel Ig-Ig architecture and unravel the molecular basis of titin-M10 linked myopathies. The severity of these pathologies correlates with the disruption of the titin-obsl1/obscurin complex. Conserved signature residues at the interface account for differences in affinity that direct the cellular sorting in cardiomyocytes. By engineering the interface signature residues of obsl1 to obscurin, and vice versa, their affinity for titin can be modulated similar to the native proteins. In single-molecule force-spectroscopy experiments, both complexes yield at forces of around 30 pN, much lower than those observed for the mechanically stable Z-disk complex of titin and telethonin, suggesting why even moderate weakening of the obsl1/obscurin-titin links has severe consequences for normal muscle functions.

Articles - 2wp3 mentioned but not cited (4)

  1. Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex. Pernigo S, Fukuzawa A, Bertz M, Holt M, Rief M, Steiner RA, Gautel M. Proc Natl Acad Sci U S A 107 2908-2913 (2010)
  2. Biophysical characterization of naturally occurring titin M10 mutations. Rudloff MW, Woosley AN, Wright NT. Protein Sci 24 946-955 (2015)
  3. Titin and obscurin: giants holding hands and discovery of a new Ig domain subset. Benian GM, Mayans O. J Mol Biol 427 707-714 (2015)
  4. Solution NMR structures of immunoglobulin-like domains 7 and 12 from obscurin-like protein 1 contribute to the structural coverage of the Human Cancer Protein Interaction Network. Pulavarti SV, Huang YJ, Pederson K, Acton TB, Xiao R, Everett JK, Prestegard JH, Montelione GT, Szyperski T. J Struct Funct Genomics 15 209-214 (2014)


Reviews citing this publication (16)

  1. Gigantic business: titin properties and function through thick and thin. Linke WA, Hamdani N. Circ Res 114 1052-1068 (2014)
  2. A rising titan: TTN review and mutation update. Chauveau C, Rowell J, Ferreiro A. Hum Mutat 35 1046-1059 (2014)
  3. The sarcomeric cytoskeleton: from molecules to motion. Gautel M, Djinović-Carugo K. J Exp Biol 219 135-145 (2016)
  4. The sarcomeric cytoskeleton: who picks up the strain? Gautel M. Curr Opin Cell Biol 23 39-46 (2011)
  5. The giant protein titin: a regulatory node that integrates myocyte signaling pathways. Krüger M, Linke WA. J Biol Chem 286 9905-9912 (2011)
  6. Cytoskeletal protein kinases: titin and its relations in mechanosensing. Gautel M. Pflugers Arch 462 119-134 (2011)
  7. Increasing Role of Titin Mutations in Neuromuscular Disorders. Savarese M, Sarparanta J, Vihola A, Udd B, Hackman P. J Neuromuscul Dis 3 293-308 (2016)
  8. Single molecule force spectroscopy using polyproteins. Hoffmann T, Dougan L. Chem Soc Rev 41 4781-4796 (2012)
  9. The M-band: The underestimated part of the sarcomere. Lange S, Pinotsis N, Agarkova I, Ehler E. Biochim Biophys Acta Mol Cell Res 1867 118440 (2020)
  10. Next Generation Methods for Single-Molecule Force Spectroscopy on Polyproteins and Receptor-Ligand Complexes. Yang B, Liu Z, Liu H, Nash MA. Front Mol Biosci 7 85 (2020)
  11. Structure of giant muscle proteins. Meyer LC, Wright NT. Front Physiol 4 368 (2013)
  12. Obscurins: unassuming giants enter the spotlight. Perry NA, Ackermann MA, Shriver M, Hu LY, Kontrogianni-Konstantopoulos A. IUBMB Life 65 479-486 (2013)
  13. Obscurin variants and inherited cardiomyopathies. Marston S. Biophys Rev 9 239-243 (2017)
  14. Mechanisms of TTNtv-Related Dilated Cardiomyopathy: Insights from Zebrafish Models. Santiago CF, Huttner IG, Fatkin D. J Cardiovasc Dev Dis 8 10 (2021)
  15. The potential of obscurin as a therapeutic target in muscle disorders. Randazzo D, Pierantozzi E, Rossi D, Sorrentino V. Expert Opin Ther Targets 21 897-910 (2017)
  16. The role of the M-band myomesin proteins in muscle integrity and cardiac disease. Lamber EP, Guicheney P, Pinotsis N. J Biomed Sci 29 18 (2022)

Articles citing this publication (22)